Cannabinoid receptor ligands
US7253189B2 · kind B2 · utility
1Cited by
8References
53Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 21, 2003 |
| Grant date | Aug 7, 2007 |
| Priority date | — |
| Expiry date | Mar 10, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound of the formulaor a pharmaceutically acceptable salt or solvate thereof, wherein: R1, R2, L1, L2, M1, M2, n, p, q, A, D, X, Y and Z are as described in the specification; pharmaceutical compositions thereof, methods of making said pharmaceutical compositions; and methods of use thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.